This knowledge has resulted in effective targeted therapies targeting this pathway; the success of BRAF inhibitors alone or in combination with MEK inhibitors [20] is a testament to the importance of molecular and mechanistic studies to understand the pathogenesis and discover relevant targets for cancer therapy. This evidence concerns the gene BRAF and cancer.